Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa News Ledger.
Press releases published on May 16, 2025
STUDIO SALE OF AFRICAN AMERICAN ARTIST VINCENT SMITH
EIN Presswire
·
May 16, 2025
May 27th at 12pm EST. LARCHMONT, NY, UNITED STATES, May 16, 2025 /EINPresswire.com/ -- Vincent D. Smith (1929 - 2003) is distinctive for his adept utilization of mixed media, striking colors, and references to the rich visual culture of the African …
Aventis Energy Inc. Announces Marketing Program
GlobeNewswire
·
May 16, 2025
VANCOUVER, British Columbia, May 16, 2025 (GLOBE NEWSWIRE) -- Aventis Energy. (“Aventis” or the “Company”) (CSE: AVE | OTC: VBAMF), is pleased to announce that it entered into an agreement (the “Agreement”) with RMK Marketing Inc. (“RMK”) on May 16, 2025, …
HPQ Silicon Reinstated for Trading
GlobeNewswire
·
May 16, 2025
MONTREAL, May 16, 2025 (GLOBE NEWSWIRE) -- HPQ Silicon Inc. (“HPQ” or the “Company”) (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08), a technology company developing next-generation processes for advanced material manufacturing, announces that on May 15, 2025, the …
HPQ Silicium : Réadmission a la cote des titres
GlobeNewswire
·
May 16, 2025
MONTRÉAL, 16 mai 2025 (GLOBE NEWSWIRE) -- HPQ Silicium inc. (« HPQ » ou « la Société ») (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08), entreprise technologique spécialisée dans le développement de nouveaux procédés industriels annonce que, le 15 mai 2025, la Bourse …
Azimut Closes $8.7 Million Private Placement
GlobeNewswire
·
May 16, 2025
LONGUEUIL, Québec, May 16, 2025 (GLOBE NEWSWIRE) -- Azimut Exploration Inc. (“Azimut” or the “Company”) (TSXV: AZM) (OTCQX: AZMTF) is pleased to report that on May 16, 2025, it has closed its previously announced non-brokered placement with Centerra Gold …
Azimut clôture un placement privé de 8,7 millions $
GlobeNewswire
·
May 16, 2025
LONGUEUIL, Québec, 16 mai 2025 (GLOBE NEWSWIRE) -- Exploration Azimut Inc. (« Azimut » ou la « Société ») (TSXV : AZM) (OTCQX : AZMTF) a le plaisir d’annoncer que le 16 mai 2025, elle a clôturé le placement privé sans intermédiaire précédemment annoncé …
US Inflation Slows, USD Faces Turning Point: EBC Financial Group on What Traders Should Watch Next
EIN Presswire
·
May 16, 2025
With CPI at a 4-year low, EBC Financial Group highlights how shifting rate bets and USD swings open new chances for currency, CFD, and gold traders. DC, UNITED STATES, May 16, 2025 /EINPresswire.com/ -- April’s U.S. Consumer Price Index (CPI) came in at …
BlueSphere Bio Appoints Alan Korman, Ph.D. as Chief Scientific Officer
GlobeNewswire
·
May 16, 2025
PITTSBURGH, May 16, 2025 (GLOBE NEWSWIRE) -- BlueSphere Bio, a clinical stage drug development company focused on novel T cell based therapies, today announced the appointment of Alan Korman, Ph.D., as Chief Scientific Officer. Dr. Korman brings extensive …
GRI Bio to Present at A.G.P.'s Annual Healthcare Company Showcase
GlobeNewswire
·
May 16, 2025
Live webcast fireside chat with Marc Hertz, PhD, Chief Executive Officer on Wednesday, May 21st at 2:40 PM ET LA JOLLA, CA, May 16, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an …
BON Announces The Launch Of Its Postbiotic Hypoglycemic Patented Ingredient Product Series And Its Cooperation Agreement
GlobeNewswire
·
May 16, 2025
XI’AN, China, May 16, 2025 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), a leading bio-ingredient solution provider in the natural, health and personal care industry, announced an exclusive cooperation agreement with …
Rio Silver Receives Conditional Approval for Acquisition of Mamaniña Exploraciones S.A.C.
GlobeNewswire
·
May 16, 2025
VANCOUVER, British Columbia, May 16, 2025 (GLOBE NEWSWIRE) -- Rio Silver Inc. (the “Company”) (TSX.V: RYO) (OTC: RYOOF) announces that, further to its announcement on March 26, 2025, it has received from the TSX Venture Exchange (the “Exchange”) …
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
May 16, 2025
SOUTH SAN FRANCISCO, Calif., May 16, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”, “Company”), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and …
Replimune Announces Dates for Fiscal Fourth Quarter and Year End 2025 Financial Results and Upcoming Investor Day
GlobeNewswire
·
May 16, 2025
WOBURN, Mass., May 16, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced that it will host a conference call on Thursday, May …
Spectral Medical to Present at the 3rd Annual H.C. Wainwright BioConnect Investor Conference
GlobeNewswire
·
May 16, 2025
TORONTO, May 16, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced that management will participate in a …
NexGold Infill Drilling Intersects New Zones of Gold Mineralization at the Goldboro Gold Project
GlobeNewswire
·
May 16, 2025
TORONTO, May 16, 2025 (GLOBE NEWSWIRE) -- NexGold Mining Corp. (TSXV: NEXG; OTCQX: NXGCF) (“NexGold” or the “Company”) is pleased to provide an update on its ongoing 25,000 metre diamond drill program initially announced on January 22, 2025 at the Company’ …
Paratek Pharmaceuticals to Present Clinical Data on NUZYRA® (omadacycline) at the American Thoracic Society (ATS) 2025 International Conference
GlobeNewswire
·
May 16, 2025
First conference presentations for: Phase 2b study for nontuberculous mycobacterial pulmonary disease (NTM PD) caused by Mycobacterium abscessus complex (MABc) Phase 3 OPTIC-2 study in moderate-to-severe community-acquired bacterial pneumonia (CABP) BOSTON …
Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
GlobeNewswire
·
May 16, 2025
SOUTH SAN FRANCISCO, Calif., May 15, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes …